Microbiome Sequencing Services Market Report
RA01874
Microbiome Sequencing Services Market by Technology (Sequencing by Synthesis, Sequencing by Ligation, Sanger Sequencing, Others), Application (Autoimmune Disorder, Cancer, Gastrointestinal Disorder, Others), End User (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, and Others), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032
Microbiome Sequencing Services Overview
Recent years have seen a significant increase in the demand for microbiome sequencing services, which has been fueled by improvements in DNA sequencing technology and increased microbiome research. Microbiome, which is a term for the collective genomes of microorganisms living in a specific habitat, is important for maintaining environmental quality, and promoting agriculture. Researchers and medical practitioners can better understand the variety, composition, and functional capacities of these microorganisms thanks to the complete examination of microbial communities provided by microbiome sequencing services. Microbiome sequencing services are used in the healthcare industry to investigate the gut microbiome and how it relates to conditions like inflammatory bowel disease, obesity, diabetes, and cancer.
Global Microbiome Sequencing Services Market Analysis
The global microbiome sequencing services market size was $1,410.85 million in 2022 and is predicted to grow with a CAGR of 9.1%, by generating a revenue of $3,256.28 million by 2032.
COVID-19 Impact on Global Microbiome Sequencing Services Market
The COVID-19 pandemic's effects on the market for global microbiome sequencing services are conflicting. On one hand, the pandemic has sparked an increase in study and curiosity about how the microbiome affects infectious viruses like COVID-19. In order to better understand how the microbiome and viruses, immunological responses, and disease severity are related, there has been an upsurge in the demand for microbiome sequencing services. The pandemic has also sped up the adoption of online and digital healthcare services.
Growing Awareness of Microbiomes’ Effect on Human Health to Drive the Market Growth
Next-generation sequencing (NGS) techniques have made microbiome sequencing faster, more affordable, and handy to a wider range of researchers and healthcare professionals. This has fueled the demand for microbiome sequencing services, as the technological know-how offers treasured insights into microbial composition, diversity, and functionality. Another vast driver is the growing research funding and collaborations in the subject of microbiome research. Government bodies, lookup and pharmaceutical businesses are investing in microbiome studies to better apprehend its function in more ailments and increase targeted interventions. This surge has created a demand for microbiome sequencing services to generate correct and reliable facts for analysis of microbiome’s effect. The rising occurrence of continual ailments worldwide, such as obesity, diabetes, and gastrointestinal disorders, has additionally contributed to the market growth of microbiome sequencing services.
High-Cost Concerns to Restrain Market Growth
The high cost of these services is one important factor that may limit the growth of the global market for microbiome sequencing services. The sequencing of the microbiome requires the use of sophisticated and complex technology, such as DNA sequencing platforms, chemicals, and bioinformatics analysis tools. Microbiome sequencing services can be prohibitively expensive, which may put off researchers, healthcare organizations, and other potential clients. Their capacity to pay for these services may be hampered by low research budgets and budgetary restrictions, particularly for lengthy or extensive undertakings. Thus, the high price can be an entry barrier, especially for smaller research centers or facilities with limited resources.
Advancements in Technology to Drive Excellent Opportunities
Microbiome sequencing has become more effective, accurate, and scalable as a result of substantial advancements in sequencing technologies, bioinformatics analysis, and data interpretation techniques over time. By enabling high-throughput sequencing at lower costs per sample, new-generation sequencing platforms, such Illumina's HiSeq and Novaseq systems, Oxford Nanopore Technologies' MinION, and Pacific Biosciences' Sequel systems, have completely changed the field. These systems enable researchers to gain more thorough and precise insights into the microbiome composition and functional potential by providing higher sequencing depth, quicker turnaround times, and improved resolution. Additionally, improvements in computer techniques and bioinformatics tools have made it easier to analyze data. These developments are predicted to create vast investment opportunities in the market.
Global Microbiome Sequencing Services Market Share, by Technology, 2022
The SBS (sequencing by synthesis) sub-segment accounted for the highest market size in 2022. SBS (sequencing by synthesis) sub-segment technologies, such as Illumina sequencing platforms, have appreciably reduced the value per base of DNA sequencing compared to previous methods. This cost-effectiveness is necessary in microbiome sequencing. The affordability of SBS has made microbiome sequencing accessible to researchers and has fueled the growth of the market. SBS platforms provide excessive scalability and throughput, allowing for the simultaneous sequencing of more than one samples in a single run. This functionality is crucial in microbiome studies. SBS enables efficient processing of an excessive volume of samples, leading to improved productiveness and quicker turnaround instances for sequencing services. SBS applied sciences supply lengthy study lengths, enabling higher assembly and analysis of complicated microbial genomes.
Global Microbiome Sequencing Services Market Share, by Application, 2022
The gastrointestinal disorders sub-segment accounted for the highest market size in 2022. Gastrointestinal disorders sub-segment has emerged as a sizable area of focus in the microbiome sequencing services market. The gastrointestinal tract harbors a complicated ecosystem of microorganisms that play an indispensable position in preserving gut fitness and average well-being. Dysbiosis, an imbalance or disruption in the gut microbiota composition, has been linked to several gastrointestinal disorders, together with inflammatory bowel sickness (IBD), irritable bowel syndrome (IBS), and colorectal cancer. This analysis helps pick out microbial signatures or dysbiotic patterns related to gastrointestinal disorders, supplying insights into attainable ailment mechanisms and novel therapeutic targets. Microbiome sequencing offerings have facilitated the identification of microbial biomarkers associated with gastrointestinal disorders. By evaluating the gut microbiota profiles of people with special ailment states, researchers can become aware of microbial taxa, functional genes, or metabolites that correlate with ailment severity, remedy response, or disorder progression.
Global Microbiome Sequencing Services Market Share, by End User, 2022
The academic research institutes sub-segment accounted for the highest market size in 2022. Academic research institutes play an indispensable function in conducting research on the microbiome. They look into the composition, diversity, and characteristics of microbial communities in various environments, which includes the human body, animals, plants, soil, water, and more. By utilizing microbiome sequencing services, researchers in academic institutions can generate information that helps unravel the complicated interactions between microorganisms and their hosts or environments. Academic researchers regularly focus on exploring the link between the microbiome and diseases. Microbiome sequencing services allow them to investigate the microbial composition and purposeful characteristics related with specific illnesses or fitness conditions. These findings provide treasured insights into disease mechanisms and achievable therapeutic targets.
Global Microbiome Sequencing Services Market Share, by Region, 2022
North America held the highest market share in the global microbiome sequencing services industry. The region's dominance in this market can be attributed to various factors. Firstly, North America is home to some of the world's major research institutions, biotechnology companies, and educational facilities with a robust focus on microbiome research. Moreover, the presence of these influential gamers has fostered the development of microbiome lookup and the demand for microbiome sequencing services.
Competitive Scenario in the Global Microbiome Sequencing Services Market
Key participants in the genomics and sequencing sectors compete fiercely in the global market for microbiome sequencing services. Established businesses and new startups coexist on the market, each vying for a competitive advantage in this developing industry. The market is dominated by a small number of well-known companies that provide a variety of microbiome sequencing services, such as sample collection, DNA extraction, library preparation, sequencing, and bioinformatics analysis. These businesses enjoy a competitive advantage thanks to their well-established brands, solid infrastructure, and wide-ranging client networks. A growing number of startups and smaller businesses, in addition to established organizations, offer microbiome sequencing services. These firms frequently concentrate on niche markets or provide specialized knowledge and custom solutions for niche.
Some of the key players in the market include Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California, Inc., BGI Group (Beijing Genomics Institute), Baseclear B.V., Novogene Corporation, Microbiome Insights Inc., and MR DNA (Molecular Research LP).
| Aspect | Particulars |
| Historical Market Estimations | 2021-2022 |
| Base Year for Market Estimation | 2022 |
| Forecast Timeline for Market Projection | 2023-2032 |
| Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
| Segmentation by Technology |
|
| Segmentation by Application |
|
| Segmentation by End user |
|
| Key Companies Profiled |
|
Q1. What is the size of the microbiome sequencing services market?
A. The size of the microbiome sequencing services market was over $1,410.85 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2032.
Q2. Which are the major companies in the microbiome sequencing services market?
A. MR DNA, Metabiomics Corp., Rancho BioSciences are some of the key players in the global microbiome sequencing services market.
Q3. Which region, among others, possesses greater investment opportunities in the near future?
A. The North America region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q4. What will be the growth rate of the North America microbiome sequencing services market?
A. North America is expected to offer significant investment opportunities in the near future in the microbiome sequencing services market.
Q5. What are the strategies opted by the leading players in this market?
A. Strategic acquisitions and partnerships and Geographic expansion and market penetration are the two key strategies opted by the operating companies in this market.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Microbiome Sequencing Services Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Microbiome Sequencing Services Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Microbiome Sequencing Services Market, By Technology
5.1. Overview
5.2 Shotgun Sequencing
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Targeted Gene Sequencing
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Rna Sequencing
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Whole Genome Sequencing
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Other Applications
5.6.1 Definition, key trends, growth factors, and opportunities
5.6.2 Market size analysis, by region, 2020-2027
5.6.3 Market share analysis, by country, 2020-2027
5.7 Research Dive Exclusive Insights
5.7.1 Market attractiveness
5.7.2 Competition heatmap
-
6. Microbiome Sequencing Services Market, By Distribution Channel
6.1. Overview
6.2 Pharmaceutical and Biotechnology Companies
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Academia/Research Institutes
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Research Dive Exclusive Insights
6.4.1 Market attractiveness
6.4.2 Competition heatmap
-
7. Microbiome Sequencing Services Market, By Atrial Fibrillation Type
7.1. Overview
7.2 Sequencing By Synthesis (SBS)
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Sequencing By Ligation (SBL)
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Pyrosequencing
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Sanger Sequencing
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 Other Technologies
7.6.1 Definition, key trends, growth factors, and opportunities
7.6.2 Market size analysis, by region, 2020-2027
7.6.3 Market share analysis, by country, 2020-2027
7.7 Research Dive Exclusive Insights
7.7.1 Market attractiveness
7.7.2 Competition heatmap
8. Microbiome Sequencing Services Market, By Region
8.1 North America
8.1.1 U.S
8.1.1.1 Market size analysis, By Technology, 2020-2027
8.1.1.2 Market size analysis, By Distribution Channel, 2020-2027
8.1.1.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.1.2 Canada
8.1.2.1 Market size analysis, By Technology, 2020-2027
8.1.2.2 Market size analysis, By Distribution Channel, 2020-2027
8.1.2.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.1.3 Mexico
8.1.3.1 Market size analysis, By Technology, 2020-2027
8.1.3.2 Market size analysis, By Distribution Channel, 2020-2027
8.1.3.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.1.4 Research Dive Exclusive Insights
8.1.4.1 Market attractiveness
8.1.4.2 Competition heatmap
8.2 Europe
8.2.1 Germany
8.2.1.1 Market size analysis, By Technology, 2020-2027
8.2.1.2 Market size analysis, By Distribution Channel, 2020-2027
8.2.1.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.2.2 UK
8.2.2.1 Market size analysis, By Technology, 2020-2027
8.2.2.2 Market size analysis, By Distribution Channel, 2020-2027
8.2.2.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.2.3 France
8.2.3.1 Market size analysis, By Technology, 2020-2027
8.2.3.2 Market size analysis, By Distribution Channel, 2020-2027
8.2.3.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.2.4 Spain
8.2.4.1 Market size analysis, By Technology, 2020-2027
8.2.4.2 Market size analysis, By Distribution Channel, 2020-2027
8.2.4.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.2.5 Italy
8.2.5.1 Market size analysis, By Technology, 2020-2027
8.2.5.2 Market size analysis, By Distribution Channel, 2020-2027
8.2.5.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.2.6 Rest of Europe
8.2.6.1 Market size analysis, By Technology, 2020-2027
8.2.6.2 Market size analysis, By Distribution Channel, 2020-2027
8.2.6.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.2.7 Research Dive Exclusive Insights
8.2.7.1 Market attractiveness
8.2.7.2 Competition heatmap
8.3 Asia-Pacific
8.3.1 China
8.3.1.1 Market size analysis, By Technology, 2020-2027
8.3.1.2 Market size analysis, By Distribution Channel, 2020-2027
8.3.1.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.3.2 Japan
8.3.2.1 Market size analysis, By Technology, 2020-2027
8.3.2.2 Market size analysis, By Distribution Channel, 2020-2027
8.3.2.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.3.3 India
8.3.3.1 Market size analysis, By Technology, 2020-2027
8.3.3.2 Market size analysis, By Distribution Channel, 2020-2027
8.3.3.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.3.4 Australia
8.3.4.1 Market size analysis, By Technology, 2020-2027
8.3.4.2 Market size analysis, By Distribution Channel, 2020-2027
8.3.4.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.3.5 South Korea
8.3.5.1 Market size analysis, By Technology, 2020-2027
8.3.5.2 Market size analysis, By Distribution Channel, 2020-2027
8.3.5.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.3.6 Rest of Asia-Pacific
8.3.6.1 Market size analysis, By Technology, 2020-2027
8.3.6.2 Market size analysis, By Distribution Channel, 2020-2027
8.3.6.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.3.7 Research Dive Exclusive Insights
8.3.7.1 Market attractiveness
8.3.7.2 Competition heatmap
8.4 LAMEA
8.4.1 Brazil
8.4.1.1 Market size analysis, By Technology, 2020-2027
8.4.1.2 Market size analysis, By Distribution Channel, 2020-2027
8.4.1.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.4.2 Saudi Arabia
8.4.2.1 Market size analysis, By Technology, 2020-2027
8.4.2.2 Market size analysis, By Distribution Channel, 2020-2027
8.4.2.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.4.3 UAE
8.4.3.1 Market size analysis, By Technology, 2020-2027
8.4.3.2 Market size analysis, By Distribution Channel, 2020-2027
8.4.3.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.4.4 South Africa
8.4.4.1 Market size analysis, By Technology, 2020-2027
8.4.4.2 Market size analysis, By Distribution Channel, 2020-2027
8.4.4.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.4.5 Rest of LAMEA
8.4.5.1 Market size analysis, By Technology, 2020-2027
8.4.5.2 Market size analysis, By Distribution Channel, 2020-2027
8.4.5.3 Market size analysis, By Atrial Fibrillation Type, 2020-2027
8.4.6 Research Dive Exclusive Insights
8.4.6.1 Market attractiveness
8.4.6.2 Competition heatmap
9. Competitive Landscape
9.1 Top winning strategies, 2020-2027
9.1.1 By strategy
9.1.2 By year
9.2 Strategic overview
9.3 Market share analysis, 2020-2027
10. Company Profiles
10.1 Baseclear B.V.
10.1.1 Overview
10.1.2 Business segments
10.1.3 Product portfolio
10.1.4 Financial performance
10.1.5 Recent developments
10.1.6 SWOT analysis
10.2 Clinical-Microbiomics A/S
10.2.1 Overview
10.2.2 Business segments
10.2.3 Product portfolio
10.2.4 Financial performance
10.2.5 Recent developments
10.2.6 SWOT analysis
10.3 Molzym GmbH & Co. Kg
10.3.1 Overview
10.3.2 Business segments
10.3.3 Product portfolio
10.3.4 Financial performance
10.3.5 Recent developments
10.3.6 SWOT analysis
10.4 Zymo Research Corp.
10.4.1 Overview
10.4.2 Business segments
10.4.3 Product portfolio
10.4.4 Financial performance
10.4.5 Recent developments
10.4.6 SWOT analysis
10.5 Rancho Biosciences
10.5.1 Overview
10.5.2 Business segments
10.5.3 Product portfolio
10.5.4 Financial performance
10.5.5 Recent developments
10.5.6 SWOT analysis
10.6 Microbiome Therapeutics, LLC.
10.6.1 Overview
10.6.2 Business segments
10.6.3 Product portfolio
10.6.4 Financial performance
10.6.5 Recent developments
10.6.6 SWOT analysis
10.7 Microbiome Insights Inc.
10.7.1 Overview
10.7.2 Business segments
10.7.3 Product portfolio
10.7.4 Financial performance
10.7.5 Recent developments
10.7.6 SWOT analysis
10.8 Openbiome
10.8.1 Overview
10.8.2 Business segments
10.8.3 Product portfolio
10.8.4 Financial performance
10.8.5 Recent developments
10.8.6 SWOT analysis
10.9 Resphera Biosciences, LLC.
10.9.1 Overview
10.9.2 Business segments
10.9.3 Product portfolio
10.9.4 Financial performance
10.9.5 Recent developments
10.9.6 SWOT analysis
10.10 MR DNA
10.10.1 Overview
10.10.2 Business segments
10.10.3 Product portfolio
10.10.4 Financial performance
10.10.5 Recent developments
10.10.6 SWOT analysis
10.11 Ubiome, Inc.
10.11.1 Overview
10.11.2 Business segments
10.11.3 Product portfolio
10.11.4 Financial performance
10.11.5 Recent developments
10.11.6 SWOT analysis
10.12 Shanghai Realbio Technology Co., Ltd
10.12.1 Overview
10.12.2 Business segments
10.12.3 Product portfolio
10.12.4 Financial performance
10.12.5 Recent developments
10.12.6 SWOT analysis
10.13 Diversigen, Inc.
10.13.1 Overview
10.13.2 Business segments
10.13.3 Product portfolio
10.13.4 Financial performance
10.13.5 Recent developments
10.13.6 SWOT analysis
10.14 MerieuxNutrisciences Corporation
10.14.1 Overview
10.14.2 Business segments
10.14.3 Product portfolio
10.14.4 Financial performance
10.14.5 Recent developments
10.14.6 SWOT analysis
10.15 Metabiomics Corp.
10.15.1 Overview
10.15.2 Business segments
10.15.3 Product portfolio
10.15.4 Financial performance
10.15.5 Recent developments
10.15.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
